0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artemisinin and Derivatives Market Research Report 2026
Published Date: 2026-03-14
|
Report Code: QYRE-Auto-12H8584
Home | Market Reports
Global Artemisinin Derivatives Market Insights and Forecast to 2028
BUY CHAPTERS

Global Artemisinin and Derivatives Market Research Report 2026

Code: QYRE-Auto-12H8584
Report
2026-03-14
Pages:130
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artemisinin and Derivatives Market

The global Artemisinin and Derivatives market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Artemisinin and Derivatives competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Artemisinin is a sesquiterpene lactone compound derived from the sweet wormwood plant, scientifically known as Artemisia annua. It is a natural product with potent antimalarial properties, making it a key component in the treatment of malaria. Artemisinin and its derivatives are crucial compounds primarily used in the treatment of malaria, showcasing potent antimalarial properties. Common artemisinin derivatives include artemether, artesunate, and dihydroartemisinin.
The North American market for Artemisinin and Derivatives is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Artemisinin and Derivatives is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Artemisinin and Derivatives include KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Ipca Laboratories, Aqre Group, Cerata Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Artemisinin and Derivatives market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artemisinin and Derivatives. The Artemisinin and Derivatives market size, estimates, and forecasts are provided in terms of shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Artemisinin and Derivatives market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Artemisinin and Derivatives manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Artemisinin and Derivatives Market Report

Report Metric Details
Report Name Artemisinin and Derivatives Market
Segment by Type
  • Artemisinin
  • Artemether
  • Artesunate
  • Dihydroartemisinin
by Application
  • Antimalarial Drugs
  • Antitumor and Anti-inflammatory Drugs
Production by Region
  • China
  • India
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Ipca Laboratories, Aqre Group, Cerata Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Artemisinin and Derivatives manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines Artemisinin and Derivatives production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes Artemisinin and Derivatives consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Artemisinin and Derivatives Market report?

Ans: The main players in the Artemisinin and Derivatives Market are KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Ipca Laboratories, Aqre Group, Cerata Pharmaceuticals

What are the Application segmentation covered in the Artemisinin and Derivatives Market report?

Ans: The Applications covered in the Artemisinin and Derivatives Market report are Antimalarial Drugs, Antitumor and Anti-inflammatory Drugs

What are the Type segmentation covered in the Artemisinin and Derivatives Market report?

Ans: The Types covered in the Artemisinin and Derivatives Market report are Artemisinin, Artemether, Artesunate, Dihydroartemisinin

1 Artemisinin and Derivatives Market Overview
1.1 Product Definition
1.2 Artemisinin and Derivatives by Type
1.2.1 Global Artemisinin and Derivatives Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Artemisinin
1.2.3 Artemether
1.2.4 Artesunate
1.2.5 Dihydroartemisinin
1.3 Artemisinin and Derivatives by Application
1.3.1 Global Artemisinin and Derivatives Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Antimalarial Drugs
1.3.3 Antitumor and Anti-inflammatory Drugs
1.4 Global Market Growth Prospects
1.4.1 Global Artemisinin and Derivatives Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Artemisinin and Derivatives Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Artemisinin and Derivatives Production Estimates and Forecasts (2021–2032)
1.4.4 Global Artemisinin and Derivatives Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Artemisinin and Derivatives Production Market Share by Manufacturers (2021–2026)
2.2 Global Artemisinin and Derivatives Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Artemisinin and Derivatives, Industry Ranking, 2024 vs 2025
2.4 Global Artemisinin and Derivatives Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Artemisinin and Derivatives Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Artemisinin and Derivatives, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Artemisinin and Derivatives, Product Offerings and Applications
2.8 Global Key Manufacturers of Artemisinin and Derivatives, Date of Entry into the Industry
2.9 Artemisinin and Derivatives Market Competitive Situation and Trends
2.9.1 Artemisinin and Derivatives Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Artemisinin and Derivatives Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Artemisinin and Derivatives Production by Region
3.1 Global Artemisinin and Derivatives Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Artemisinin and Derivatives Production Value by Region (2021–2032)
3.2.1 Global Artemisinin and Derivatives Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Artemisinin and Derivatives by Region (2027–2032)
3.3 Global Artemisinin and Derivatives Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Artemisinin and Derivatives Production Volume by Region (2021–2032)
3.4.1 Global Artemisinin and Derivatives Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Artemisinin and Derivatives by Region (2027–2032)
3.5 Global Artemisinin and Derivatives Market Price Analysis by Region (2021–2026)
3.6 Global Artemisinin and Derivatives Production, Value, and Year-over-Year Growth
3.6.1 China Artemisinin and Derivatives Production Value Estimates and Forecasts (2021–2032)
3.6.2 India Artemisinin and Derivatives Production Value Estimates and Forecasts (2021–2032)
4 Artemisinin and Derivatives Consumption by Region
4.1 Global Artemisinin and Derivatives Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Artemisinin and Derivatives Consumption by Region (2021–2032)
4.2.1 Global Artemisinin and Derivatives Consumption by Region (2021–2026)
4.2.2 Global Artemisinin and Derivatives Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Artemisinin and Derivatives Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Artemisinin and Derivatives Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Artemisinin and Derivatives Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Artemisinin and Derivatives Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Artemisinin and Derivatives Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Artemisinin and Derivatives Production by Type (2021–2032)
5.1.1 Global Artemisinin and Derivatives Production by Type (2021–2026)
5.1.2 Global Artemisinin and Derivatives Production by Type (2027–2032)
5.1.3 Global Artemisinin and Derivatives Production Market Share by Type (2021–2032)
5.2 Global Artemisinin and Derivatives Production Value by Type (2021–2032)
5.2.1 Global Artemisinin and Derivatives Production Value by Type (2021–2026)
5.2.2 Global Artemisinin and Derivatives Production Value by Type (2027–2032)
5.2.3 Global Artemisinin and Derivatives Production Value Market Share by Type (2021–2032)
5.3 Global Artemisinin and Derivatives Price by Type (2021–2032)
6 Segment by Application
6.1 Global Artemisinin and Derivatives Production by Application (2021–2032)
6.1.1 Global Artemisinin and Derivatives Production by Application (2021–2026)
6.1.2 Global Artemisinin and Derivatives Production by Application (2027–2032)
6.1.3 Global Artemisinin and Derivatives Production Market Share by Application (2021–2032)
6.2 Global Artemisinin and Derivatives Production Value by Application (2021–2032)
6.2.1 Global Artemisinin and Derivatives Production Value by Application (2021–2026)
6.2.2 Global Artemisinin and Derivatives Production Value by Application (2027–2032)
6.2.3 Global Artemisinin and Derivatives Production Value Market Share by Application (2021–2032)
6.3 Global Artemisinin and Derivatives Price by Application (2021–2032)
7 Key Companies Profiled
7.1 KPC Pharmaceuticals
7.1.1 KPC Pharmaceuticals Artemisinin and Derivatives Company Information
7.1.2 KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolio
7.1.3 KPC Pharmaceuticals Artemisinin and Derivatives Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 KPC Pharmaceuticals Main Business and Markets Served
7.1.5 KPC Pharmaceuticals Recent Developments/Updates
7.2 Guilin Nantang Pharmaceutical
7.2.1 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Company Information
7.2.2 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolio
7.2.3 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Guilin Nantang Pharmaceutical Main Business and Markets Served
7.2.5 Guilin Nantang Pharmaceutical Recent Developments/Updates
7.3 Chongqing Kerui Nanhai Pharmaceutical
7.3.1 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Company Information
7.3.2 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolio
7.3.3 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Chongqing Kerui Nanhai Pharmaceutical Main Business and Markets Served
7.3.5 Chongqing Kerui Nanhai Pharmaceutical Recent Developments/Updates
7.4 Sichuan Xieli Pharmaceutical
7.4.1 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Company Information
7.4.2 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolio
7.4.3 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Sichuan Xieli Pharmaceutical Main Business and Markets Served
7.4.5 Sichuan Xieli Pharmaceutical Recent Developments/Updates
7.5 Ipca Laboratories
7.5.1 Ipca Laboratories Artemisinin and Derivatives Company Information
7.5.2 Ipca Laboratories Artemisinin and Derivatives Product Portfolio
7.5.3 Ipca Laboratories Artemisinin and Derivatives Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Ipca Laboratories Main Business and Markets Served
7.5.5 Ipca Laboratories Recent Developments/Updates
7.6 Aqre Group
7.6.1 Aqre Group Artemisinin and Derivatives Company Information
7.6.2 Aqre Group Artemisinin and Derivatives Product Portfolio
7.6.3 Aqre Group Artemisinin and Derivatives Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Aqre Group Main Business and Markets Served
7.6.5 Aqre Group Recent Developments/Updates
7.7 Cerata Pharmaceuticals
7.7.1 Cerata Pharmaceuticals Artemisinin and Derivatives Company Information
7.7.2 Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolio
7.7.3 Cerata Pharmaceuticals Artemisinin and Derivatives Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Cerata Pharmaceuticals Main Business and Markets Served
7.7.5 Cerata Pharmaceuticals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Artemisinin and Derivatives Industry Chain Analysis
8.2 Artemisinin and Derivatives Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Artemisinin and Derivatives Production Modes and Processes
8.4 Artemisinin and Derivatives Sales and Marketing
8.4.1 Artemisinin and Derivatives Sales Channels
8.4.2 Artemisinin and Derivatives Distributors
8.5 Artemisinin and Derivatives Customer Analysis
9 Artemisinin and Derivatives Market Dynamics
9.1 Artemisinin and Derivatives Industry Trends
9.2 Artemisinin and Derivatives Market Drivers
9.3 Artemisinin and Derivatives Market Challenges
9.4 Artemisinin and Derivatives Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Artemisinin and Derivatives Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Artemisinin and Derivatives Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Artemisinin and Derivatives Production Capacity (Tons) by Manufacturers in 2025
 Table 4. Global Artemisinin and Derivatives Production by Manufacturers (Tons), 2021–2026
 Table 5. Global Artemisinin and Derivatives Production Market Share by Manufacturers (2021–2026)
 Table 6. Global Artemisinin and Derivatives Production Value by Manufacturers (US$ Million), 2021–2026
 Table 7. Global Artemisinin and Derivatives Production Value Share by Manufacturers (2021–2026)
 Table 8. Global Key Players of Artemisinin and Derivatives, Industry Ranking, 2024 vs 2025
 Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Artemisinin and Derivatives Production Value, 2025
 Table 10. Global Market Artemisinin and Derivatives Average Price by Manufacturers (US$/Kg), 2021–2026
 Table 11. Global Key Manufacturers of Artemisinin and Derivatives, Manufacturing Footprints and Headquarters
 Table 12. Global Key Manufacturers of Artemisinin and Derivatives, Product Offerings and Applications
 Table 13. Global Key Manufacturers of Artemisinin and Derivatives, Date of Entry into the Industry
 Table 14. Global Artemisinin and Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Artemisinin and Derivatives Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Artemisinin and Derivatives Production Value (US$ Million) by Region (2021–2026)
 Table 18. Global Artemisinin and Derivatives Production Value Market Share by Region (2021–2026)
 Table 19. Global Artemisinin and Derivatives Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 20. Global Artemisinin and Derivatives Production Value Market Share Forecast by Region (2027–2032)
 Table 21. Global Artemisinin and Derivatives Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Artemisinin and Derivatives Production (Tons) by Region (2021–2026)
 Table 23. Global Artemisinin and Derivatives Production Market Share by Region (2021–2026)
 Table 24. Global Artemisinin and Derivatives Production (Tons) Forecast by Region (2027–2032)
 Table 25. Global Artemisinin and Derivatives Production Market Share Forecast by Region (2027–2032)
 Table 26. Global Artemisinin and Derivatives Market Average Price (US$/Kg) by Region (2021–2026)
 Table 27. Global Artemisinin and Derivatives Market Average Price (US$/Kg) by Region (2027–2032)
 Table 28. Global Artemisinin and Derivatives Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 29. Global Artemisinin and Derivatives Consumption by Region (Tons), 2021–2026
 Table 30. Global Artemisinin and Derivatives Consumption Market Share by Region (2021–2026)
 Table 31. Global Artemisinin and Derivatives Forecasted Consumption by Region (Tons), 2027–2032
 Table 32. Global Artemisinin and Derivatives Forecasted Consumption Market Share by Region (2027–2032)
 Table 33. North America Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 34. North America Artemisinin and Derivatives Consumption by Country (Tons), 2021–2026
 Table 35. North America Artemisinin and Derivatives Consumption by Country (Tons), 2027–2032
 Table 36. Europe Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 37. Europe Artemisinin and Derivatives Consumption by Country (Tons), 2021–2026
 Table 38. Europe Artemisinin and Derivatives Consumption by Country (Tons), 2027–2032
 Table 39. Asia Pacific Artemisinin and Derivatives Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 40. Asia Pacific Artemisinin and Derivatives Consumption by Region (Tons), 2021–2026
 Table 41. Asia Pacific Artemisinin and Derivatives Consumption by Region (Tons), 2027–2032
 Table 42. Latin America, Middle East & Africa Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 43. Latin America, Middle East & Africa Artemisinin and Derivatives Consumption by Country (Tons), 2021–2026
 Table 44. Latin America, Middle East & Africa Artemisinin and Derivatives Consumption by Country (Tons), 2027–2032
 Table 45. Global Artemisinin and Derivatives Production (Tons) by Type (2021–2026)
 Table 46. Global Artemisinin and Derivatives Production (Tons) by Type (2027–2032)
 Table 47. Global Artemisinin and Derivatives Production Market Share by Type (2021–2026)
 Table 48. Global Artemisinin and Derivatives Production Market Share by Type (2027–2032)
 Table 49. Global Artemisinin and Derivatives Production Value (US$ Million) by Type (2021–2026)
 Table 50. Global Artemisinin and Derivatives Production Value (US$ Million) by Type (2027–2032)
 Table 51. Global Artemisinin and Derivatives Production Value Market Share by Type (2021–2026)
 Table 52. Global Artemisinin and Derivatives Production Value Market Share by Type (2027–2032)
 Table 53. Global Artemisinin and Derivatives Price (US$/Kg) by Type (2021–2026)
 Table 54. Global Artemisinin and Derivatives Price (US$/Kg) by Type (2027–2032)
 Table 55. Global Artemisinin and Derivatives Production (Tons) by Application (2021–2026)
 Table 56. Global Artemisinin and Derivatives Production (Tons) by Application (2027–2032)
 Table 57. Global Artemisinin and Derivatives Production Market Share by Application (2021–2026)
 Table 58. Global Artemisinin and Derivatives Production Market Share by Application (2027–2032)
 Table 59. Global Artemisinin and Derivatives Production Value (US$ Million) by Application (2021–2026)
 Table 60. Global Artemisinin and Derivatives Production Value (US$ Million) by Application (2027–2032)
 Table 61. Global Artemisinin and Derivatives Production Value Market Share by Application (2021–2026)
 Table 62. Global Artemisinin and Derivatives Production Value Market Share by Application (2027–2032)
 Table 63. Global Artemisinin and Derivatives Price (US$/Kg) by Application (2021–2026)
 Table 64. Global Artemisinin and Derivatives Price (US$/Kg) by Application (2027–2032)
 Table 65. KPC Pharmaceuticals Artemisinin and Derivatives Company Information
 Table 66. KPC Pharmaceuticals Artemisinin and Derivatives Specification and Application
 Table 67. KPC Pharmaceuticals Artemisinin and Derivatives Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 68. KPC Pharmaceuticals Main Business and Markets Served
 Table 69. KPC Pharmaceuticals Recent Developments/Updates
 Table 70. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Company Information
 Table 71. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Specification and Application
 Table 72. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 73. Guilin Nantang Pharmaceutical Main Business and Markets Served
 Table 74. Guilin Nantang Pharmaceutical Recent Developments/Updates
 Table 75. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Company Information
 Table 76. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Specification and Application
 Table 77. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 78. Chongqing Kerui Nanhai Pharmaceutical Main Business and Markets Served
 Table 79. Chongqing Kerui Nanhai Pharmaceutical Recent Developments/Updates
 Table 80. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Company Information
 Table 81. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Specification and Application
 Table 82. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 83. Sichuan Xieli Pharmaceutical Main Business and Markets Served
 Table 84. Sichuan Xieli Pharmaceutical Recent Developments/Updates
 Table 85. Ipca Laboratories Artemisinin and Derivatives Company Information
 Table 86. Ipca Laboratories Artemisinin and Derivatives Specification and Application
 Table 87. Ipca Laboratories Artemisinin and Derivatives Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 88. Ipca Laboratories Main Business and Markets Served
 Table 89. Ipca Laboratories Recent Developments/Updates
 Table 90. Aqre Group Artemisinin and Derivatives Company Information
 Table 91. Aqre Group Artemisinin and Derivatives Specification and Application
 Table 92. Aqre Group Artemisinin and Derivatives Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 93. Aqre Group Main Business and Markets Served
 Table 94. Aqre Group Recent Developments/Updates
 Table 95. Cerata Pharmaceuticals Artemisinin and Derivatives Company Information
 Table 96. Cerata Pharmaceuticals Artemisinin and Derivatives Specification and Application
 Table 97. Cerata Pharmaceuticals Artemisinin and Derivatives Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 98. Cerata Pharmaceuticals Main Business and Markets Served
 Table 99. Cerata Pharmaceuticals Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Artemisinin and Derivatives Distributors List
 Table 103. Artemisinin and Derivatives Customers List
 Table 104. Artemisinin and Derivatives Market Trends
 Table 105. Artemisinin and Derivatives Market Drivers
 Table 106. Artemisinin and Derivatives Market Challenges
 Table 107. Artemisinin and Derivatives Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Artemisinin and Derivatives
 Figure 2. Global Artemisinin and Derivatives Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Artemisinin and Derivatives Market Share by Type: 2025 vs 2032
 Figure 4. Artemisinin Product Picture
 Figure 5. Artemether Product Picture
 Figure 6. Artesunate Product Picture
 Figure 7. Dihydroartemisinin Product Picture
 Figure 8. Global Artemisinin and Derivatives Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Artemisinin and Derivatives Market Share by Application: 2025 vs 2032
 Figure 10. Antimalarial Drugs
 Figure 11. Antitumor and Anti-inflammatory Drugs
 Figure 12. Global Artemisinin and Derivatives Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Artemisinin and Derivatives Production Value (US$ Million), 2021–2032
 Figure 14. Global Artemisinin and Derivatives Production Capacity (Tons), 2021–2032
 Figure 15. Global Artemisinin and Derivatives Production (Tons), 2021–2032
 Figure 16. Global Artemisinin and Derivatives Average Price (US$/Kg), 2021–2032
 Figure 17. Artemisinin and Derivatives Report Years Considered
 Figure 18. Artemisinin and Derivatives Production Share by Manufacturers in 2025
 Figure 19. Global Artemisinin and Derivatives Production Value Share by Manufacturers (2025)
 Figure 20. Artemisinin and Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Top 5 and Top 10 Global Players: Market Share by Artemisinin and Derivatives Revenue in 2025
 Figure 22. Global Artemisinin and Derivatives Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 23. Global Artemisinin and Derivatives Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 24. Global Artemisinin and Derivatives Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 25. Global Artemisinin and Derivatives Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 26. China Artemisinin and Derivatives Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 27. India Artemisinin and Derivatives Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 28. Global Artemisinin and Derivatives Consumption by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 29. Global Artemisinin and Derivatives Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 30. North America Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 31. North America Artemisinin and Derivatives Consumption Market Share by Country (2021–2032)
 Figure 32. U.S. Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 33. Canada Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 34. Europe Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 35. Europe Artemisinin and Derivatives Consumption Market Share by Country (2021–2032)
 Figure 36. Germany Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 37. France Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 38. U.K. Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 39. Italy Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 40. Russia Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 41. Asia Pacific Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 42. Asia Pacific Artemisinin and Derivatives Consumption Market Share by Region (2021–2032)
 Figure 43. China Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 44. Japan Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 45. South Korea Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 46. China Taiwan Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 47. Southeast Asia Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 48. India Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 49. Latin America, Middle East & Africa Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 50. Latin America, Middle East & Africa Artemisinin and Derivatives Consumption Market Share by Country (2021–2032)
 Figure 51. Mexico Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 52. Brazil Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 53. Turkey Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 54. GCC Countries Artemisinin and Derivatives Consumption and Growth Rate (Tons), 2021–2032
 Figure 55. Global Production Market Share of Artemisinin and Derivatives by Type (2021–2032)
 Figure 56. Global Production Value Market Share of Artemisinin and Derivatives by Type (2021–2032)
 Figure 57. Global Artemisinin and Derivatives Price (US$/Kg) by Type (2021–2032)
 Figure 58. Global Production Market Share of Artemisinin and Derivatives by Application (2021–2032)
 Figure 59. Global Production Value Market Share of Artemisinin and Derivatives by Application (2021–2032)
 Figure 60. Global Artemisinin and Derivatives Price (US$/Kg) by Application (2021–2032)
 Figure 61. Artemisinin and Derivatives Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension